GH and IGF-I binding in adipose tissue, liver, and skeletal muscle in response to milk intake level in piglets

Circulating levels of insulin-like growth factor-1 and associated binding proteins in plasma and mRNA expression in tissues of growing pigs on a low threonine diet

The aim was to determine whether dietary threonine levels affected hepatic insulin-like growth factor-1 (IGF-1) mRNA expression as well as plasma IGF-1 concentration and IGF binding protein (IGFBP) profile in growing pigs. Two male 6-week-old pigs from each of seven litters were used. Each littermate was assigned to one of two diets, control or low threonine (LT), providing per kg 14·3 MJ digestible energy in both diets, 170 g protein in the control diet and 167 g protein in the LT diet. The control diet contained all essential amino acids in the recommended amounts, including 8·2 g threonine per kg. The LT diet was similar but contained only 5·1 g threonine per kg. Pigs were pair-fed these diets for 3 weeks. Growth rate and food efficiency of pigs given the LT diet were significantly lower than those of pigs given the control diet (P 0·001). Plasma IGF-1 concentration of pigs given the LT diet was proportionately 0·44 lower than that of pigs given the control diet (P 0·01). Plasma free threonine concentration of pigs given the LT diet was lower than that of the pigs given the control diet (P 0·001). Plasma IGFBP2 level of pigs given the LT diet was significantly higher than that of pigs given the control diet (P 0·05). Pigs given the LT diet had a significantly lower plasma IGFBP3 level compared with their littermates given the control diet (P 0·05) suggesting that clearance rate of circulating IGF-1 was higher in the LT group. Dietary threonine level did not affect IGF-1 mRNA abundance in the liver. It is concluded that lower plasma IGF-1 level caused by reduced dietary threonine level may have been partly due to increased clearance rate of circulating IGF-1 but not due to IGF-1 gene expression in the liver.

Decreased expression of the IGF-II gene during porcine adipose cell differentiation

IGF-I and IGF-II are known to regulate cell development and recent data suggest a possible role of IGF-II on adipose tissue development. This study was undertaken to examine the IGF system gene expression in porcine differentiating adipocytes. Both adipocytes and stromal-vascular (s/v) cells were isolated from subcutaneous adipose tissue collected from 7-day-old piglets. s/v cells were cultured in chemically defined medium. Compared with isolated adipocytes, IGF-II and IGFBP-5 mRNA levels were very high in freshly isolated s/v cells, whereas IGF-I mRNA levels were lower in s/v cells than in adipocytes. Between day 0 and day 6 of culture, IGF-II and IGFBP-5 gene expression decreased whereas expression levels of late markers of adipocyte differentiation were up-regulated. Cell differentiation was also associated with an increase in the expression of IGF-I, insulin and IGF receptor genes. The current findings suggest that IGF-I and IGF-II have different effects on porcine adipose cell development.

Basic principles of muscle development and growth in meat-producing mammals as affected by the insulin-like growth factor (IGF) system

This presentation aims to describe how the basic events in prenatal muscle development and postnatal muscle growth are controlled by the insulin-like growth factor system (IGF). The prenatal events (myogenesis) cover the rate of proliferation, the rate and extent of fusion, and the differentiation of three myoblast populations, giving rise to primary fibers, secondary fibers, and a satellite cell population, respectively. The number of muscle fibers, a key determinant of the postnatal growth rate, is fixed late in gestation. The postnatal events contributing to myofiber hypertrophy comprise satellite cell proliferation and differentiation, and protein turnover. Muscle cell cultures produce IGFs and IGF binding proteins (IGFBPs) in various degrees depending on the origin (species, muscle type) and state of development of these cells, suggesting an autocrine/paracrine mode of action of IGF-related factors. In vivo studies and results based on cell lines or primary cell cultures show that IGF-I and IGF-II stimulate both proliferation and differentiation of myoblasts and satellite cells in a time and concentration-dependent way, via interaction with type I IGF receptors. However, IGF binding proteins (IGFBP) may either inhibit or potentiate the stimulating effects of IGFs on proliferation or differentiation. During postnatal growth in vivo or in fully differentiated muscle cells in culture, IGF-I stimulates the rate of protein synthesis and inhibits the rate of protein degradation, thereby enhancing myofiber hypertrophy. The possible roles and actions of the IGF system in regulating and determining muscle growth as affected by developmental stage and age, muscle type, feeding levels, treatment with growth hormone and selection for growth performance are discussed.

Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system

White adipose tissue plays a key role in the regulation of the energy balance of vertebrates. This tissue is also now recognized to secrete a variety of factors such as leptin, which is thought to be involved in the modulation of adipose mass. Unlike other tissues, adipose tissue mass has considerable capacity to expand. The review deals primarily on the regulation of development and metabolism of adipose tissue by growth hormone (GH) and the insulin-like growth factor (IGF) system, with a special focus on the pig. The anti-insulin effects of GH are well-documented in pigs as in other species. In vitro exposure of adipose precursor cells to GH leads to a decrease in differentiation of those cells in pigs, in contrast to data obtained in murine cell lines. In vivo treatment and prolonged in vitro incubation of adipose tissue or isolated adipocytes with GH result in a decrease in glucose transport and lipogenesis, especially at the level of the fatty acid synthase gene, resulting in a reduction of the lipid content and adipose tissue mass. The mechanism by which GH antagonizes insulin stimulation of lipogenesis is still unresolved, as it is not mediated by protein kinase A, protein kinase C and Janus kinase-2 at the signaling level, or upstream stimulatory factor 1 or sterol regulatory element binding protein-1 at the transcriptional level. GH is apparently the main regulator of IGF-I mRNA expression in adipose tissue, however, the effects of IGF-I on this tissue are rather unclear.